Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
Foresite Capital Fund IV, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)
- Filing manager
- Foresite Capital Fund IV, L.P.
- Reporting owner
- James B. Tananbaum
- Beneficially owned shares
- 1,454,616 shares
- Large-stake signal
-
Ownership
7.6%Beneficial ownership of this reported class.
Shares
1,454,616 sharesShares beneficially owned as disclosed.
Event date
30 Sep 2025Date tied to the ownership event or amendment.
Accepted by SEC
14 Nov 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 7.6%
- Symbol
- LYEL
- Shares outstanding
- 19,139,684 shares
- SEC form
- SCHEDULE 13G/A
- Accepted by SEC
- 14 Nov 2025, 16:05:18 UTC
- Event date
- 30 Sep 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Foresite Capital Fund IV, L.P. disclosed 7.6% ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL) on 30 Sep 2025.
Key facts
- Foresite Capital Fund IV, L.P. filed SCHEDULE 13G/A for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).
- Disclosed ownership: 7.6%.
- Date of event: 30 Sep 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:05.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (7)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Foresite Capital Fund IV, L.P. | 4.2% | 800,339 | 800,339 | 0 | /s/ James Tananbaum | James Tananbaum, Managing Member of the General Partner | |
| Foresite Capital Management IV, LLC | 4.2% | 800,339 | 800,339 | 0 | /s/ James Tananbaum | James Tananbaum, Managing Member | |
| Foresite Capital Fund V, L.P. | 2.5% | 477,078 | 477,078 | 0 | /s/ James Tananbaum | James Tananbaum, Managing Member of the General Partner | |
| Foresite Capital Management V, LLC | 2.5% | 477,078 | 477,078 | 0 | /s/ James Tananbaum | James Tananbaum, Managing Member | |
| Foresite Capital Opportunity Fund V, L.P. | 0.9% | 177,199 | 177,199 | 0 | /s/ James Tananbaum | James Tananbaum, Managing Member of the General Partner | |
| Foresite Capital Opportunity Management V, LLC | 0.9% | 177,199 | 177,199 | 0 | /s/ James Tananbaum | James Tananbaum, Managing Member | |
| James B. Tananbaum | 7.6% | 1,454,616 | 1,454,616 | 0 | /s/ James Tananbaum | James Tananbaum |
CIK / CUSIP context first